ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2014 ACR/ARHP Annual Meeting

November 14-19, 2014. Boston, MA.

View by Title View Sessions
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 885
    A 2-Week Single-Blind, Randomized, 3-Arm Proof of Concept Study of the Effects of Secukinumab (anti-IL17 mAb), Canakinumab (anti-IL-1 b mAb), or Corticosteroids on Initial Disease Activity Scores in Patients with PMR, Followed By an Open-Label Extension to Assess Safety and Effect Duration
  • Abstract Number: 776
    A Candidate Gene Approach Identifies IL33 as a Novel Genetic Risk Factor for GCA
  • Abstract Number: 1878
    A Combination of Celecoxib and Famciclovir Is Efficacious in the Treatment of Fibromyalgia: Results of a Phase IIa Randomized, Double-Blind, Placebo-Controlled Study
  • Abstract Number: 2580
    A Comparison of Baseline Characteristics and Real-Life Effectiveness of Anti-TNF Therapy in Non-Radiographic Axial Spondyloarthritis Versus Ankylosing Spondylitis – a Single Center Cohort Study
  • Abstract Number: 673
    A Comparison of Rheumatoid Arthritis and Systemic Lupus Erythematosus Trial Design: Ways to Improve Positive Trials in Systemic Lupus Erythematosus
  • Abstract Number: 1374
    A Comparison of the Risk for Cardiovascular Event in Patients with Rheumatoid Arthritis Treated with Biologic Disease Modifiers and Patients Treated with Methotrexate Only
  • Abstract Number: L2
    A Comparison of Three Treatment Strategies in Recent Onset DMARD Naïve Juvenile Idiopathic Arthritis: 3-Months Results of the BeSt for Kids-Study
  • Abstract Number: 912
    A Consensus Hybrid Definition Using a Conjoint Analysis Is the Proposed As Response Criteria for Minimal and Moderate Improvement for Adult Polymyositis and Dermatomyositis Clincal Trials
  • Abstract Number: 299
    A Controlled Trial of Intra-Articular Corticosteroids with or without Methotrexate in Oligoarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 2065
    A Cross-Sectional Analysis of Psychological Symptoms, Sleep Quality, and Functional Balance in Fibromyalgia
  • Abstract Number: 1299
    A Cross-Sectional Study of Mental Health Symptoms and Mental Health Care in Pediatric SLE/MCTD Patients and Their Peers
  • Abstract Number: 145
    A Cut-Off Value Analysis By Ultrasound for the Diagnosis of Giant Cell Arteritis (GCA)
  • Abstract Number: 1349
    A Decision Support Tool to Improve Herpes Zoster Vaccination Rates Among Patients Starting Biologic Medications
  • Abstract Number: 1167
    A Description and Comparison of Treatments for Low Back Pain in the United States
  • Abstract Number: 526
    A Descriptive and Comparative Study of the Transcriptome from Salivary Exosomes of Sjögren’s Syndrome Patients Using RNA-Seq
  • Abstract Number: 909
    A Diagnostic Protocol for Giant Cell Arteritis (GCA) Using Ultrasound Assessment
  • Abstract Number: 729
    A Dilated Esophagus Is an Independent Risk Factor for Interstitial Lung Disease in SSc
  • Abstract Number: 2445
    A Distinct Profile of Circulating Microparticles Is Associated with Disease Features in Rheumatoid Arthritis Patients and Impairs Endothelial Functionality in Vitro
  • Abstract Number: 1476
    A Dose Response Relationship Between Shared Epitope and ACPA Level: But Not All SE Alleles Are Created Equal
  • Abstract Number: 1679
    A Double Blind Randomized Control Trial of Oral Tadalafil in Interstitial Lung Disease of Scleroderma
  • Abstract Number: 1948
    A Dual Role for IFN-γ in Development of Peripheral B Cells in Lupus-Prone MRL/Lpr Mice
  • Abstract Number: 415
    a Dual-Center, Double Blind Randomized Study for a New Scientific Approach in Assessment of Tender Joints in Inflammatory Arthritis Using the Smart Joint Assessor Glove Device (Smart JAG Device)
  • Abstract Number: 1694
    a Feasibility Study of Subjective and Objective Assessment of Sublingual Abnormalities in Systemic Sclerosis
  • Abstract Number: 618
    A Gender Bias in Gut Microbiota of SKG Mice Colonized with a Limited Bacterial Consortium Associated with Severity of Spondyloarthritis and Ileitis Triggered By Beta-Glucan
  • Abstract Number: 78
    a HPLC-SRM-MS Based Method for the Detection and Quantification of Methotrexate Used at Doses in Clinical Practice for Patients with Rheumatological Disease in Urine
  • Abstract Number: 2350
    A Humanized Monoclonal Antibody Raised Against a Heat Shock Protein Epitope Suppresses Autoimmune Inflammatory Diseases By Skewing the Immune System Selectively Towards an Anti-Inflammatory Response
  • Abstract Number: 1316
    A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials
  • Abstract Number: 2942
    A Longitudinal Population-Based Study 1994-2010 of Age, Period, and Cohort Effects in the Prevalence of Arthritis: The Effect of Improving Socioeconomic Status and Increasing Obesity over Time
  • Abstract Number: 345
    A Low Salt Diet Ameliorates Clinical Manifestations in Collagen-Induced Arthritis
  • Abstract Number: 1074
    A Meta-Analysis of the Risk of Venous Thromboembolism in Inflammatory Rheumatic Diseases
  • Abstract Number: 2261
    A Meta-Anlaysis of Bisphosphonate and Parathyroid Hormone (PTH) Use in Osteoporosis
  • Abstract Number: 2896
    a Multi-Center Double-Blind, Randomized, Controlled Trial (db-RCT) to Evaluate the Effectiveness and Safety of Co-Administered Traumeel® (Tr14) and Zeel® (Ze14) Intra‑articular (IA) Injections Versus IA Placebo in Patients with Moderate-to-Severe Pain Associated with OA of the Knee
  • Abstract Number: 1259
    A Multi-Center Study for Validation of a New Assay for Anti-Melanoma Differentiation-Associated Gene 5 (MDA5) Autoantibody
  • Abstract Number: 933
    A Multi-Center, Double-Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients with Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results
  • Abstract Number: 2438
    A Multi-Centre Survey of Tolerability Problems for Patients on Regular Methotrexate
  • Abstract Number: 1928
    A Multicenter, Prospective Cohort Study Using Nailfold Videocapillaroscopy and Other Clinical Characteristics to Determine the Risk of Developing New Digital Ulcers in Patients with Systemic Sclerosis
  • Abstract Number: 928
    A Multinational Study of the Epidemiology, Treatment and Outcome of Childhood Arthritis: Preliminary Data from 6,940 Patients
  • Abstract Number: 2443
    A New Meta-Analysis on Safety of Ketoprofen Vs Ibuprofen and Diclofenac: Risk and Benefit of Nsaids Beyond Efficacy Meta-Analysis
  • Abstract Number: 1257
    A New Multianalyte Assay for Detection of Dermatomyositis-Specific Autoantibodies Undetectable By Commercially Available Immunoassays
  • Abstract Number: 2077
    A New Tender Point on the Plantar Arch in Primary Juvenile Fibromyalgia: A Potential Point to be Considered
  • Abstract Number: 2309
    A Novel Approach to Assess Wait-Times to Rheumatologists
  • Abstract Number: 2691
    A Novel CD123–CD11c– Dendritic Cell Subset Increased in Relation to Disease Activity in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1951
    A Novel CD27(-) Spleen Tyrosine Kinase (Syk) Bright Memory B-Cell Subset Is Expanded in SLE
  • Abstract Number: 1132
    A Novel Epigenetic Mark, Histone H1 Fucosylation, Orchestrates Macrophage Differentiation and Plasticity By Remodeling the Enhancer Landscape in Rheumatoid Arthritis
  • Abstract Number: 1886
    A Novel Monocyte-Specific Transcript Underlies the Chromosome 21q22 Intergenic Genetic Association in Ankylosing Spondylitis
  • Abstract Number: 2796
    A Novel Mouse Model of Osteochondromagenesis By Deleting NFATc1 in Mesenchymal Progenitors and Postnatal Chondrocytes
  • Abstract Number: 1940
    A Novel Murine Model of B Cell-Mediated Glomerular Injury Is Mediated By Cytokines
  • Abstract Number: 1630
    A Novel NMR Biomarker of Inflammation (GlycA) Is Elevated in Systemic Lupus Erythematosus
  • Abstract Number: 1830
    A Novel Population Care Model in Rheumatoid Arthritis – Significant Improvement in Quality and Reduction in Cost of Care
  • Abstract Number: 674
    A Novel Strategy to  Identify and Evaluate Approved Drugs and Treatments for Repositioning As Therapies for Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 329
    A Novel, Small Molecule Cyclin-Dependent Kinase 4/6 Inhibitor As the New Option for Treatment of Rheumatoid Arthritis
  • Abstract Number: 856
    A Pathogenic Role for the Gut Microbiota in Murine Antiphospholipid Syndrome and Lupus
  • Abstract Number: 1158
    A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence
  • Abstract Number: 640
    A Peptide Mimic Inhibits the Cross Reaction of Anti-DNA Antibodies with Glomerular Antigens
  • Abstract Number: 2295
    A Pharmacometric Based Analysis of the Occurrence of Selected Safety Events of Special Interest and Canakinumab Exposure in Systemic Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 1487
    A Phase 1 Dose-Ranging Repeated-Dose Trial of Parenteral Staphylococcal Protein A (PRTX-100) in Patients with Active Rheumatoid Arthritis on Methotrexate or Leflunamide Therapy
  • Abstract Number: 1493
    A Phase 1 Study of FPA008, an Anti-Colony Stimulating Factor 1 Receptor (anti-CSF1R) Antibody in Healthy Volunteers and Subjects with Rheumatoid Arthritis (RA): Preliminary Results
  • Abstract Number: 2233
    A PHASE 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of Apremilast (CC-10004) in Subjects with Erosive Hand Osteoarthritis
  • Abstract Number: 2835
    A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis
  • Abstract Number: L6
    A PHASE 2, Randomized, Double-Blind Comparison of the Efficacy and Safety of PF-04171327 (1, 5, 10, 15 mg QD) Vs 5 and 10 Mg Prednisone QD or Placebo in Subjects with Rheumatoid Arthritis (RA) over 8 Weeks Followed By a 4-Week Taper of Study Drug
  • Abstract Number: 2826
    A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate
  • Abstract Number: 948
    A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
  • Abstract Number: 249
    A Phase 3 Open-Label Trial of Low-Dose Solumatrix Diclofenac in Patients with Osteoarthritis Pain: Impact of Long-Term Administration on Patient-Reported Outcomes
  • Abstract Number: 602
    A Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-Week) Improvements in Physical Function
  • Abstract Number: 1502
    A Phase I Trial Comparing PF-05280586 (A Potential Biosimilar) and Rituximab in Subjects with Active Rheumatoid Arthritis
  • Abstract Number: 952
    A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Evaluate the Efficacy and Safety of Clazakizumab, an Anti-IL-6 Monoclonal Antibody, in Adults with Active Psoriatic Arthritis
  • Abstract Number: 2828
    A Physically Demanding Job May Amplify the Effect of Disease Activity on the Development of Syndesmophytes in Patients with Ankylosing Spondylitis
  • Abstract Number: 2377
    A Pilot Randomized Controlled Trial of a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients
  • Abstract Number: 1321
    A Pilot Study to Evaluate the Feasibility of Conducting Juvenile Localized Scleroderma Comparative Effectiveness Treatment Studies
  • Abstract Number: 922
    A Potential Role for TLR4 Activation in Osteoarthritis Associated Pain
  • Abstract Number: 914
    A Predictive Model of Disease Outcome in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Serum Biomarkers
  • Abstract Number: 2824
    A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
  • Abstract Number: L24
    A Progressive Increase in T Follicular Helper Cells Marks the Transition from Benign to Symptomatic Autoimmunity
  • Abstract Number: 2078
    A Proposed Simple 3-Variable Index for Identification of Fibromyalgia, Analogous to Classification Criteria for RA and SLE
  • Abstract Number: 1642
    A Prospective Study of Vitamin D Effects on T Cells Phenotype in Patients with Systemic Lupus Erythematosus Treated with Different Regimens of Supplementation for Two Years
  • Abstract Number: 561
    A Psychometric Analysis of Outcome Measures in Trials of Peripheral Spondyloarthritis
  • Abstract Number: 1981
    A Qualitative Analysis of Methotrexate Injection Videos on Youtube
  • Abstract Number: 1343
    A Quality Improvement Initiative to Improve Pneumococcal Vaccination Rates in Immunosuppressed Patients
  • Abstract Number: 1448
    A Questionnaire Assessment of Knowledge about Methotrexate of Patients with Rheumatoid Arthritis
  • Abstract Number: 490
    A Randomised Controlled Trial Evaluating the Effect of Humira upon Endothelial Function in ACPA Positive Rheumatoid Arthritis – an Interim Analysis
  • Abstract Number: 1824
    A Randomized Double-Blind Placebo-Controlled Trial of Vitamin D Supplementation in Juvenile-Onset Systemic Lupus Erythematosus: Improvement in Disease Activity and Fatigue Scores
  • Abstract Number: 2825
    A Randomized, Double-Blind, Phase 3 Equivalence Trial Comparing the Etanercept Biosimilar, HD203, with Etanercept (Enbrel®), in Combination with Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 2938
    A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
  • Abstract Number: 1509
    A Randomized, Double-Blind, Three-Arm, Parallel Group, Single-Dose Study to Compare the Pharmacokinetics, Safety, and Tolerability of Three Formulations of Infliximab (CT-P13, EU-sourced Infliximab and US-sourced Infliximab) in Healthy Volunteers
  • Abstract Number: 128
    A Rapid 4- Joint Ultrasonographic Score to Daily Monitoring Disease Activity in Patients with Rheumatoid Arthritis: Validity and Sensitivity to Change
  • Abstract Number: 1077
    A Real-World Characterization of US Patients with “Moderate-to-Severe” Systemic Lupus Erythematosus
  • Abstract Number: 1826
    A Renal Activity Index May Predict Histological Activity in Lupus Nephritis in Children
  • Abstract Number: 1927
    A Retrospective Look at the Recurrence of Digital Ulcers in Patients with Scleroderma after Discontinuation of Oral Treprostinil
  • Abstract Number: 9
    A Risk-Stratified Perioperative Management Strategy for Antiphospholipid Antibody Positive Patients Undergoing Kidney Transplantation
  • Abstract Number: 1050
    A Role for Purinergic Receptor Signalling in Basic Calcium Phosphate Crystal-Induced Inflammation
  • Abstract Number: 1621
    A Shift Towards Trans-Signalling Explains Relatively Low CRP Despite an Active Interleukin-6 (IL-6)/IL-6-Receptor (IL-6R) System in SLE
  • Abstract Number: 2634
    A Signal of Improvement in Lupus Disease Activity at 3 Months Predicts Further Valid Improvement at 6 Months
  • Abstract Number: 882
    A Signature of microRNAs Overexpressed in Inflamed Temporal Arteries of Patients with Giant Cell Arteritis
  • Abstract Number: 1107
    A Strong Association Between Memory Loss and Word Finding Difficulties in Fibromyalgia
  • Abstract Number: 505
    A Structured Approach for Comparative Benefit-Risk Assessment of Rituximab for the Treatment of Rheumatoid Arthritis
  • Abstract Number: 577
    A Substantial Decrease in Work Productivity and Physical Health-Related Quality of Life in Chronic Back Pain of Recent Onset: Data from the SPACE-Cohort
  • Abstract Number: 1358
    A Systematic Analysis of the Safety of Prescribing Anti-Rheumatic Immunosuppressive and Biologic Drugs in Pregnant Women
  • Abstract Number: 1660
    A Systematic Review and Network Meta-Analysis of Cyclophosphamide and Mycophenolate Mofetil in Lupus Nephritis
  • Abstract Number: 962
    A Systematic Review and Network Meta-Analysis of the Risk of Serious Infections with Immunosuppressives for Lupus Nephritis
  • Abstract Number: 2325
    A Systematic Review of the Educational Approach of Occupational Therapy for Rheumatoid Arthritis
  • Abstract Number: 851
    A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study
  • Abstract Number: 2422
    A Tailored Approach to Reduce Dose of TNF Inhibitors Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Rheumatoid Arthritis over One and Two Years: A Prospective Cohort Study
  • Abstract Number: 2102
    A Tissue-Specific Lincrna in the TRAF1-C5 Risk Locus As a Putative Cis-Regulator, Bridging Genetics and Disease
  • Abstract Number: 2034
    A Treat-to-Target Strategy Preserves Work Capacity in Early Rheumatoid Arthritis (RA)
  • Abstract Number: 937
    A Unique Role for IL-18 Receptor-α in Monocyte Migration in RA and K/BxN Serum Transfer Arthritis
  • Abstract Number: 456
    AAA-Atpase p97 Regulates Autophagy-Associated Cell Death in Arthritis
  • Abstract Number: 504
    Abatacept after Rituximab in Rheumatoid Arthritis. a Pan-European Collaboration of RA Registries
  • Abstract Number: 472
    Abatacept Can be Used Safely for RA Patients with Interstitial Lung Disease
  • Abstract Number: 1578
    Abatacept Improves Synovitis As Assessed By Magnetic Resonance Imaging (MRI) in Psoriatic Arthritis – Preliminary Analysis from a Single Centre, Placebo-Controlled, Crossover Study
  • Abstract Number: 2934
    Abatacept reduces Circulating Effector Memory T-Helper Cells in Patients with Primary Sjögren’s Syndrome
  • Abstract Number: 2151
    Abatacept Related Infections: No Association with Gammaglobulin Reduction
  • Abstract Number: 411
    ABCB1 and ABCG2 Drug-Efflux Transporters Function and Its Association with Disease Activity in a Cohort of Patients with Rheumatoid Arthritis
  • Abstract Number: 1769
    Abdominal Visceral Adipose Tissue Measured By DXA As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides
  • Abstract Number: 1592
    Ability of Clinical Variables to Predict Radiographic Damage in Psoriatic Arthritis
  • Abstract Number: 741
    Abnormal Right Ventricular Longitudinal Strain Detected in Systemic Sclerosis Patients Prior to Abnormalities in Conventional Measures of Right Ventricular Size and Function
  • Abstract Number: 1213
    Absence of Hormone Responsive Estrogen Receptor Alpha Reduces the Activation of Plasmacytoid Dendritic Cells in Lupus Prone Mice
  • Abstract Number: 1030
    ABT-122, a Novel Dual Variable Domain (DVD)-IgTM, Targeting TNF and IL-17, Inhibits Peripheral Blood Mononuclear Cell Production of GM-CSF and Decreases Lymphocyte Expression of CXCR4 in Healthy Subjects
  • Abstract Number: 858
    ABT-199, a Potent and Selective BCL-2 Inhibitor, Prevents Lupus Nephritis in the Spontaneous NZB/W F1 Mouse Model By Depleting Selective Lymphocyte Populations While Sparing Platelets
  • Abstract Number: 1441
    Accelerated Aging in DMARD and Treatment Naive Early Rheumatoid Arthritis Patients Measured By a Stem Cell Assay Is Associated with Increased LDL and Is Linked to Impaired Cardiopulmonary Function
  • Abstract Number: 1364
    Accelerated Diastolic Dysfunction in Premenopausal Women with Rheumatoid Arthritis
  • Abstract Number: 883
    Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study
  • Abstract Number: 1303
    Accuracy of Laboratory Measures and Clinical Renal Activity Indices for Reflecting Biopsy-Proven Lupus Nephritis (LN) Activity
  • Abstract Number: 2289
    Accuracy of the Use of Administrative Diagnostic Codes to Identify Pediatric in-Patient Musculoskeletal Conditions in an African Tertiary Hospital
  • Abstract Number: 942
    ACR/EULAR Remission in RA patients in Clinical Practice – Does Substitution of Patient Global with Pain Score Change Remission Rates? Data from the Danish Danbio Registry
  • Abstract Number: 2681
    Activated SLE-T Cells Enhance the Interferon-Alpha Production By Plasmacytoid Dendritic Cells Stimulated By RNA-IC
  • Abstract Number: 2949
    Activation of AMP-Activated Protein Kinase (AMPK) By Berberine Limits Both Surgical Knee Instability-Induced and Aging-Related Osteoarthritis in Mice
  • Abstract Number: 23
    Activation of EPAC1/2 Is Essential for Osteoclast Formation By Modulating NFkB Nuclear Translocation and Actin Cytoskeleton Rearrangements
  • Abstract Number: 2100
    Activation of NFkβ Pathways in Sjögren’s Syndrome Related Lymphomagenesis-Role of the His159Tyr Mutation of the BAFF-R Receptor
  • Abstract Number: 1195
    Activation of the nlrp3 Inflammasome By an Endogenous TLR2 Ligand in Rheumatoid Arthritis
  • Abstract Number: 3006
    Activation of the Thromboxane A2 Receptor By 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma
  • Abstract Number: 2348
    Activatory Fc Gamma Receptor IV Plays a Crucial Role in Pathogenesis of Experimental Immune Complex Mediated Chronic Arthritis
  • Abstract Number: 855
    Active and Structural Lesions on MRI of the Sacroiliac Joints Predict Major Clinical Responses in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Etanercept
  • Abstract Number: 936
    Active Invasion of Periodontal Bacteria into Synovial Joint Exacerbates Collagen-Induced Arthritis in Disease-Prone B10 Riii Mice
  • Abstract Number: 693
    Acute Myocarditis in Patients with Systemic Lupus Erythematosus: Experience from Affiliated Hospitals of Catholic University of Korea
  • Abstract Number: 2203
    Adalimumab Therapy Improves Insulin Sensitivity in Non-Diabetic Psoriatic Patients: A 6-Month Prospective Study
  • Abstract Number: 2509
    ADAM-10 As a Tocilizumab Treatment Predictive Factor in Rheumatoid Arthritis
  • Abstract Number: 1028
    ADAM-10 Plays Monocyte Migration and Adhesion in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 1629
    Added Value of the Determination of Anti-Ribosomal and Anti-Ku Antibodies for Diagnosis of Systemic Lupus Erythematosus
  • Abstract Number: 2484
    Adding an Initial Six-Month Course of Infliximab to an Active Combination Treatment Is Cost Saving in Working-Aged Early Rheumatoid Arthritis Patients
  • Abstract Number: 22
    Adenosine a2A Receptor (A2AR) Stimulation Inhibits Osteoclast Differentiation and Promotes Osteoblast Formation By Regulation of Axon Guidance Proteins
  • Abstract Number: 2947
    Adenosine a2A Receptor As a Potential New Therapeutic Target for the Prevention/Treatment of Osteoarthritis
  • Abstract Number: 1729
    Adenosine A2A Receptor (A2AR) Promotes Collagen Type 3 Expression Via β-Catenin Activation
  • Abstract Number: 19
    Adenosine Receptors Stimulate Bone Regeneration
  • Abstract Number: 2381
    Adherence to a Treat-to-Target (T2T) Strategy in Early Rheumatoid Arthritis. Is It Feasible in Daily Clinical Practice?
  • Abstract Number: 2316
    Adherence to Denosumab in a Large Healthcare System
  • Abstract Number: 2382
    Adherence to Dmards in the First Six Months of Treatment in Early Arthritis Patients; Comparing Three Adherence Measures
  • Abstract Number: 181
    Adherence to Treatment Recommendations of Gout: A Patient Survey in China
  • Abstract Number: 966
    Adiponectin Is an Endogenous Anti-Fibrotic and Target in Systemic Sclerosis: Novel Link Between Fibrosis and Metabolism
  • Abstract Number: 532
    Adipose Tissue Is Prominent in Salivary Glands of Sjögren’s Syndrome Patients and Appears to Influence the Autoimmune Microenvironment in These Organs
  • Abstract Number: 1305
    Adiposity and Adipokines Are Associated with Insulin Resistance in Pediatric Systemic Lupus Erythematosus
  • Abstract Number: 478
    Adverse Events and Infections in Patients with Rheumatoid Arthritis Treated with Conventional Drugs or Biologic Agents: A Real World Study
  • Abstract Number: 1828
    Adverse Pregnancy Outcomes in Adolescents and Young Women with Systemic Lupus Erythematosus: A National Estimate
  • Abstract Number: 61
    Advocating for Pediatric Rheumatology Care in the Mid-Canadian Provinces: Large Geographic Area, Large Pediatric Population, Low Number of Pediatric Rheumatologists and Allied Health Workers Identified As Unique Challenges
  • Abstract Number: 1859
    Age-Specific Predictors of Mortality in SLE
  • Abstract Number: 1936
    Ageism, Fear, and Competing Co-Morbidities – Why Older Patients May Not Seek Care for Restricting Back Pain: A Qualitative Study
  • Abstract Number: 2140
    Agreement Among FDG-PET/CT, Ultrasound and Physical Examination in Patients with Inflammatory Arthritis
  • Abstract Number: 283
    Agreement Between Enthesitis Evaluation By Manual Palpation and Dolorimetry in Juvenile Spondyloarthritis
  • Abstract Number: 2322
    Aim for Better Gout Control: A Retrospective Analysis of Preventable Hospital Admissions for Gout
  • Abstract Number: 1199
    Alarmins S100A8/S100A9 Aggravate Osteophyte Formation in Experimental Osteoarthritis and Predict Osteophyte Progression in EARLY Human Osteoarthritis in the Dutch Check Cohort
  • Abstract Number: 2442
    Aligning Ethics with Digital Health Technologies and Shared Decision-Making: Interview Accounts of Patients and Clinicians
  • Abstract Number: 160
    All Men with Gout Should be Screened for Erectile Dysfunction
  • Abstract Number: 960
    Allogeneic Mesenchymal Stem Cell Transplantation for Lupus Nephritis Patients Refractory to Conventional Therapy
  • Abstract Number: 2185
    Alterations in B Cell Complement Processing Related to a Lupus-Associated Variant in Complement Receptor 2
  • Abstract Number: 2695
    Alterations in B Cell Subsets and BAFF Levels in Autoimmune Rheumatic Diseases Treated with B Cell Depletion Therapy: Rituximab
  • Abstract Number: 1737
    Altered Phenotype and Function of Senescent Regulatory T Cells in Rheumatoid Arthritis
  • Abstract Number: 2845
    Altered Plasticity of Inflammatory CD4 T Cells Contributing to Th17 Shift in Rheumatoid Arthritis
  • Abstract Number: 1498
    ALX-0061, an Anti-IL-6R Nanobody® for use in Rheumatoid Arthritis, Demonstrates a Different in Vitro Profile As Compared to Tocilizumab
  • Abstract Number: 3003
    Am80 Ameliorates Bleomycin-Induced Dermal Fibrosis By Suppressing the Pro-Fibrotic Phenotype of Fibroblasts, Endothelial Cells, and Immune Cells
  • Abstract Number: 3011
    Ambulatory Gait Analysis in Clinical Practice: Single or Dual Task Conditions?
  • Abstract Number: 1986
    Ambulatory Rheumatology Curriculum: Effect of Multimodal Curriculum Enhancement
  • Abstract Number: 2344
    Amelioration of Collagen-Induced Arthritis By Water-Soluble Fullerene C60(OH)36 Nanoparticles through the Inhibition of Angiogenesis
  • Abstract Number: 934
    Amelioration of Inflammatory Arthritis By Anti-TNF Therapy Is Associated with Restoration of Lymphatic Contraction
  • Abstract Number: 857
    Amelioration of Systemic Lupus Erythematosus (SLE) in NZM 2328 Mice By Selectively Blocking Engagement of Two BAFF Receptors
  • Abstract Number: 84
    Amerindian Ancestry Influences Polyautoimmunity
  • Abstract Number: 2039
    Among Persons Assayed with Lower Serum Interleukin-1 Beta (IL-1β) Levels, Serum Androstenedione (Δ4A) and Testosterone (T) Were Significantly Lower in a Community-Based Cohort of Rheumatoid Arthritis Multi-Years before Clinical Onset (Pre-RA) Than in Non-RA Matched Control (CN) Subjects
  • Abstract Number: 2888
    Amount of Smoking, Duration of Smoking Cessation, and Their Interaction with Silica Exposure in the Risk of Rheumatoid Arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis Study
  • Abstract Number: 327
    AMPK Activation in Inflammatory Arthritis
  • Abstract Number: 221
    An Analysis of Age-Related Loss of Skeletal Muscle Mass and Its Significance on Osteoarthritis in a Korean Population
  • Abstract Number: 1514
    An Analysis of in-Vitro Cytokine Inhibition Profiles of Tofacitinib and Other Janus Kinase Inhibitors at Clinically-Meaningful Concentrations
  • Abstract Number: 1757
    An Analysis of the Incidence and Characteristics of ANCA Positive Vasculitis before and after the Christchurch Earthquake
  • Abstract Number: 2842
    An Anti CD123 Monoclonal Antibody (CSL362) Depletes Plasmacytoid Dendritic Cells and Inhibits CpG Upregulated IFNα Production and IFNα-Inducible Gene Expression in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1703
    An Association of Anti-PM/Scl Antibody Reactivity with Risk of Malignancy in Scleroderma
  • Abstract Number: 2630
    An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
  • Abstract Number: 266
    An Examination of the Interaction of Opioid Use, Pain, and Depression
  • Abstract Number: 2240
    An Exploratory 4-Week Study of a P2X3 Antagonist AF-219 in the Treatment of Patients with Osteoarthritis (OA) of the Knee
  • Abstract Number: 930
    An Exploratory Analysis of Predictors of Response from 12-Weeks of Canakinumab Therapy in Patients with Active Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 880
    An Immunochip Study Confirms a Strong Contribution of HLA Class I and II Genes in the Susceptibility to Giant Cell Arteritis
  • Abstract Number: 1555
    An Indirect Comparison and Cost per Responder Analysis of Adalimumab, Methotrexate (MTX) and Apremilast in the Treatment of MTX-naïve Psoriatic Arthritis (PsA) Patients
  • Abstract Number: 1680
    an Indirect Comparisons Analysis of Medications Used for Treatment of Raynaud’s Phenomenon
  • Abstract Number: 240
    An Observational Study on the Influence of Glucocorticoid Exposure on Bone
  • Abstract Number: 1253
    Anakinra – a Promising New Therapy for Idiopathic Recurrent Pericarditis
  • Abstract Number: 1254
    Anakinra for the Management of Resistant Idiopathic Recurrent Pericarditis in Adults
  • Abstract Number: 1103
    Analgesic and Anti-Hyperalgesic Effects of Deep Dry Needling Therapy in Fibromyalgia Patients
  • Abstract Number: 1972
    Analysis of Anakinra in Primary Human Cell Systems Reveals an in Vitro Signature for Skin-Related Side Effects
  • Abstract Number: 1416
    Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis
  • Abstract Number: 1264
    Analysis of Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Severity of Physical Dysfunction after Treatment for Polymyositis and Dermatomyositis
  • Abstract Number: 2489
    Analysis of Early Neutropenia, Clinical Response, and Serious Infection Events in Patients Receiving Tofacitinib for Rheumatoid Arthritis
  • Abstract Number: 1759
    Analysis of Employment, Work Disability and Quality of Life of Patients with ANCA-Associated Vasculitis
  • Abstract Number: 1517
    Analysis of Gene Expression Fluctuation with Abatacept Highlights the Involvement of the Proteasome Pathway As a Mechanism of Action of Abatacept in Rheumatoid Arthritis
  • Abstract Number: 460
    Analysis of Non-Melanoma Skin Cancer Across the Tofacitinib Rheumatoid Arthritis Clinical Program
  • Abstract Number: 1485
    Analysis of Patient-Reported Outcomes during Treatment with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRá, in the Randomized Phase 2b Earth Explorer 1 Study
  • Abstract Number: 464
    Analysis of Pooled Data from Two Randomized Controlled Trials and Their Open-Label Extensions: Long-Term Safety in Rheumatoid Arthritis before and after Certolizumab Pegol Dose Increase/Decrease
  • Abstract Number: 1320
    Analysis of Risk Factors for Thrombosis in Pediatric Patients with Systemic Lupus Erythematosus
  • Abstract Number: 513
    Analysis of Shoulder Joint Destruction in Rheumatoid Arthritis Patients Treated with Biologics
  • Abstract Number: 2478
    Analysis of the Clinical Sustained Response after Retreatment with a Lower Dose of Rituximab in Patients with Chronic Inflammatory Arthropathies
  • Abstract Number: 2063
    Analysis of the Fibromyalgia Rapid Screening Tool Spanish Version to Detect Fibromyalgia in Primary Health Care Centers
  • Abstract Number: 615
    Analysis of the Gut Transcriptome in HLA-B27 Transgenic Rats By RNA-Seq Reveals Prominent Interferon and IL-23/IL-17 Axis Signatures
  • Abstract Number: 237
    Analysis of Vitamin D Receptor Gene Polymorphisms and Bone Mineral Density in a Population of Women with Rheumatoid Arthritis in Use of Steroid
  • Abstract Number: 2521
    Analysis on Predictors for Long-Term Clinical Efficacies of Golimumab in Patients with Rheumatoid Arthritis
  • Abstract Number: 2436
    Analytical and Clinical Evaluation of an Immunoassay for Estimating Immunogenicity of Infliximab and Etanercept in Indian Population
  • Abstract Number: 180
    Analytical Comparison Between Point of Care Uric Acid Testing Meters
  • Abstract Number: 1029
    Anandamide and Related Eicosanoids Decrease the Production of Pro-Inflammatory Cytokines in Synovial Fibroblasts By a COX-2 Dependent Mechanism: Involvement of Calcium and TRP Channels
  • Abstract Number: 2643
    Angiogenic and Antiangiogenic Factors in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1376
    Angiographic Pattern Among Rheumatoid Arthritis Patients Who Are Hospitalized Due to Acute Coronary Syndrome
  • Abstract Number: 38
    Angiopoietin-like 4 Is over-Expressed in Rheumatoid Arthritis: A Potential Role in Pathological Bone Resorption
  • Abstract Number: 2604
    Ankylosing Spondylitis and Non- Radiographic Axial Spondyloarthritis :      the Same Syndrome or Different Diseases? Analysis from Esperanza Cohort
  • Abstract Number: 888
    Annual Medical Care Expenditures Among US Adults with Gout, 2005 – 2011
  • Abstract Number: 980
    Annual Medical Care Expenditures Among US Adults with Osteoarthritis, 2008 – 2011
  • Abstract Number: 1160
    Annual Real-Practice Costs of Biologics for 200 Cases with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated By Tight Control and Treat to Target Strategy Permitting Dose Reduction
  • Abstract Number: 2464
    Anti-Arthritic Effect of Tubastatin A, a Novel Histone Deacetylases-6 Inhibitor, Is Mediated By Stabilization of IkB Via Suppression of Ubiquitin-Proteasome Pathway
  • Abstract Number: 2392
    Anti-Carbamylated Antibodies (anti-CarPA) Are Associated with Long Term Disability and Increased Disease Activity in Patients with Early Inflammatory Arthritis: Results from the Norfolk Arthritis Register (NOAR)
  • Abstract Number: 442
    Anti-Carbamylated Protein Antibody Levels Are Elevated in Seropositive Rheumatoid Arthritis and Correlate with Anti-Sa/Citrullinated Vimentin Antibody Levels
  • Abstract Number: 437
    Anti-Citrullinated Heat Shock Protein 90 Antibodies Identified in Bronchoalveolar Lavage Fluid Are a Marker of Lung-Specific Immune Responses
  • Abstract Number: 1377
    Anti-Citrullinated Peptide Antibody Titers and the Prevalence of Interstitial Lung Disease in Patients with and without Rheumatoid Arthritis
  • Abstract Number: 993
    Anti-Citrullinated Proteins Antibodies Promote Synovial Fibroblast Migration in Rheumatoid Arthritis
  • Abstract Number: 2797
    Anti-Citrullinated Proteins Antibodies Promotes Osteoclastogenesis and Bone Destruction in Rheumatoid Arthritis
  • Abstract Number: 1638
    Anti-Dense Fine Speckled 70 Antibodies:  Long-Term Followup Study of Clinical Associations in a US Laboratory Patient Population
  • Abstract Number: 598
    Anti-Drug Antibodies As a Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis
  • Abstract Number: 3002
    Anti-Fibrotic Effects of a Newly Discovered HGF Receptor Carboxy-Terminal Fragment in Systemic Sclerosis
  • Abstract Number: 769
    Anti-Fibrotic Effects of an Investigational Drug: Bis-Oxetanyl Sulfoxide
  • Abstract Number: 2345
    Anti-IL-6 Receptor Antibody Prevents Deterioration in Bone Structure in a Mouse Model of Collagen-Induced Arthritis
  • Abstract Number: 323
    Anti-Inflammatory Marine Compound, Lyy-B2, Ameliorates Rheumatoid Arthritis through Inhibition of Osteoclast Differentiation
  • Abstract Number: 2457
    Anti-Major Histocompatibility Complex Class I-Related Chain a (MICA) Antibodies in Rheumatoid Arthritis Patients with Interstitial Lung Disease
  • Abstract Number: 1037
    Anti-MDA5 Antibody Associated Myositis Compared to DM Patient: A Distinct Muscular Pattern Associated with a shared  IFN Signature
  • Abstract Number: 1266
    Anti-MDA5 Is Associated with Rapidly-Progressive Interstitial Lung Disease and Poor Survival in U.S. Patients with Amyopathic and Myopathic Dermatomyositis
  • Abstract Number: 1835
    Anti-Osteoporosis Medication Use after Hip or Vertebral Fracture
  • Abstract Number: 1317
    Anti-p155/140 Autoantibodies and Selected Features at Illness Onset Are Associated with a Chronic Course of Illness in the Juvenile Idiopathic Inflammatory Myopathies
  • Abstract Number: 1474
    Anti-Peptidyl Arginine Deiminase 4 Antibodies in African-Americans with Rheumatoid Arthritis and  Radiographic Scores
  • Abstract Number: 398
    Anti-Rheumatic Therapy Decreases Syndecan-1 Shedding in Rheumatoid Arthritis (RA)
  • Abstract Number: 2991
    Anti-Ribosomal P Antibody Is a Key Autoantibody Associated with Complications of NP-SLE with High-Levels of CSF IL-8
  • Abstract Number: 1827
    Anti-Ro and Anti-La Antibodies in the General Pregnant Population
  • Abstract Number: 2543
    Anti-Ro/SSA Positive Incomplete Sjögren’s Syndrome
  • Abstract Number: 1209
    Anti-Scavenger Receptor Autoantibodies Disrupted Marginal Zone Macrophage Integrity Via Bruton’s Tyrosine Kinase
  • Abstract Number: 2759
    Anti-TNF Treatment for Refractory Vascular Involvement of Behçet’s Syndrome
  • Abstract Number: 1741
    Anti-TNFα Treatment Increases IL-17A+ and IL-22+ T Cells in Spondyloarthritis Regardless of Concomittant Gut Inflammation
  • Abstract Number: 929
    Antibiotic Exposure and the Development of Juvenile Idiopathic Arthritis: A Population-Based Case-Control Study
  • Abstract Number: 2019
    Antibodies to Citrullinated Clusterin, Filaggrin, Vimentin, and Fibrinogen Are Associated with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis
  • Abstract Number: 2539
    Antibodies to Human Interferon-Inducible Protein-16 Are Present in Primary Sjögren’s Syndrome and Systemic Lupus, but Are Rare in Dermatomyositis
  • Abstract Number: 1620
    Antibody to Malondialdehyde-Acetaldehyde Adducts (MAA) As a Potential Biomarker of Inflammation in Systemic Lupus Erythrematosus (SLE)
  • Abstract Number: 1743
    Antigen-Specificity Regulates Peripheral Homeostasis of Regulatory T Cells
  • Abstract Number: 871
    Antimalarials Regulate TLR7/8 Mediated Macrophage Activation Via Epigenetic Modification at the TNFα Promoter
  • Abstract Number: 1308
    Antinucleosome Antibodies As Potential Diagnostic and Prognostic Biomarkers in Childhood Onset Systemic Lupus Erythematosus
  • Abstract Number: 10
    Antiphospholipid Antibodies and Neuropsychiatric Events in Pediatric Patients
  • Abstract Number: 1702
    Antiphospholipid Antibodies in Systemic Sclerosis: Prevalence and Clinical Significance?
  • Abstract Number: 2867
    Antiphospholipid Antibodies Promote the Release of Neutrophil Extracellular Traps:  a New Mechanism of Thrombosis in the Antiphospholipid Syndrome
  • Abstract Number: 2868
    Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository Initial Analysis
  • Abstract Number: 17
    Antiphospholipid Syndrome Following Infection: A Systematic Review of Case Reports
  • Abstract Number: L7
    Antiphospholipid Syndrome without Anticoagulation: 0utcome of 50 Patients
  • Abstract Number: 5
    Antiphospholipid-Associated Nephropathy Is a Risk for Developing Arterial Thromboses in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2108
    Anxiety in Caregivers of Patients with Chronic Rheumatic Conditions
  • Abstract Number: 1102
    Anxiety in Fibromyalgia Patients
  • Abstract Number: 2786
    Aortitis: Outcomes from a Cohort of 196 Patients
  • Abstract Number: 984
    Apolipoprotein B Is a Target of T and B Cell Responses in a Subgroup of Patients with Lyme Disease
  • Abstract Number: 1791
    Applicability of the 2006 European League Against Rheumatism (EULAR) Criteria for the Classification of Henoch-Schönlein Purpura. an Analysis Based on 766 Patients with Cutaneous Vasculitis
  • Abstract Number: 1989
    Application of an Experiential Learning Framework for Clinician Scholar Educator Training in a Rheumatology Fellowship
  • Abstract Number: 2714
    Application of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis in Korean Patients with Raynaud Phenomenon
  • Abstract Number: 666
    Approach to Discriminate Treatment Impact in Both Moderate and Severe SLE: The Atacicept Phase IIb Trial Design
  • Abstract Number: 2355
    Apremilast, a Novel Phosphodiesterase 4 Inhibitor, and Methotrexate Independently Prevent Inflammation in Vivo and in Vitro
  • Abstract Number: 1561
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
  • Abstract Number: 955
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of a Phase 3, Randomized, Controlled Trial
  • Abstract Number: 1565
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Improvement of Pain, Fatigue, and Disability in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
  • Abstract Number: 1590
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvements in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
  • Abstract Number: 548
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
  • Abstract Number: 1543
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in the Signs and Symptoms of Psoriatic Arthritis in DMARD-Naive Patients: Results from a Phase 3, Randomized, Controlled Trial
  • Abstract Number: 1572
    Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
  • Abstract Number: 1267
    Are Anti-SRP Auto-Antibodies Specific for Myositis?
  • Abstract Number: 2523
    Are Biologic Agents Effective on the Treatment of Secondary Amyloidosis: A Multicenter Report on Turkish Rheumatoid Arthritis and Ankylosing Spondylitis Patients
  • Abstract Number: 140
    Are Entheses Ultrasound Findings Similar in Axial Spa Patients and in Athletes?
  • Abstract Number: 1365
    ARE Erosions a Disappearing Feature in Rheumatoid Arthritis (RA)?Joint Damage in Patients with EARLY RA at 10 YEARS after Diagnosis
  • Abstract Number: 1789
    Are EULAR/Printo/PRES Classification Criteria Appropriate for Classification of IgA Vasculitis in Adults?
  • Abstract Number: 2084
    Are Genetic Markers Associated with Myocardial Infarction in Patients with Early Rheumatoid Arthritis?
  • Abstract Number: 1802
    Are Outcomes after Total Knee Arthroplasty Worsening over Time? a Time-Trends Study of Activity Limitation and Pain Outcomes
  • Abstract Number: 2109
    Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in SLE?
  • Abstract Number: 2519
    Are Patients with Rheumatoid Arthritis Initiating a TNF Biologic Comparable to Patients Initiating a Non TNF?
  • Abstract Number: 1661
    Are Repeat Renal Biopsies Important in Managing Lupus Nephritis Flares?
  • Abstract Number: 1368
    Are Tender Joints Better Than Synovitis to Predict Structural Damage in Rheumatoid Arthritis?
  • Abstract Number: 1601
    Are There Gender Specific Differences in Patient Characteristics at Initiation of Biologic Treatment in Ankylosing Spondylitis and Psoriatic Arthritis?
  • Abstract Number: 2055
    Are There Immunological Abnormalities in Fibromyalgia Patients: Flow Cytometry Analysis
  • Abstract Number: 2557
    Are We over-Treating with Nsaids Our Early Axial Spa Patients? Results from the DESIR Cohort
  • Abstract Number: 1153
    Area of Residence and Socio-Economic Factors Significantly Affect Access to Biological Therapy for Rheumatoid Arthritis Patients in Romania
  • Abstract Number: 1771
    Arterial Thrombotic Events in Systemic Vasculitis
  • Abstract Number: 441
    Arthritis Associated Autoantibodies in Non-Rheumatoid Arthritis Patients with Mucosal Inflammation
  • Abstract Number: 59
    Assessing Dietary Habits in a Large Cohort of Rheumatoid Arthritis and Psoriatic Arthritis Patients: Results of the Spanish Imid Consortium
  • Abstract Number: 2886
    Assessing Rheumatology Fellows’ Teaching Skills Using the Objective Structured Teaching Exercise (OSTE)
  • Abstract Number: 1172
    Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand
  • Abstract Number: 2411
    Assessing Treatment Durability of Infliximab in the Management of Psoriatic Arthritis and Rheumatoid Arthritis Patients in a Canadian Setting
  • Abstract Number: 1351
    Assessment of ACR Endorsed Quality Indicators in Rheumatoid Arthritis Patients – a Quality Improvement Initiative
  • Abstract Number: 69
    Assessment of Exercise Status in Routine Care Using Patient Reported Outcomes: Initiating Exercise Is Associated with Better Outcomes Than No Exercise
  • Abstract Number: 487
    Assessment of Lipid Changes in Patients with Early Rheumatoid Arthritis Treated with Tofacitinib or Methotrexate over 24 Months
  • Abstract Number: 758
    Assessment of mRNA Gene Expression Based on Forearm Skin Score in Systemic Sclerosis Patients
  • Abstract Number: 2637
    Assessment of Plaque Thickness and Area in Patients with SLE As Measures of Atherosclerosis – Associations with Disease Activity
  • Abstract Number: 1246
    Assessment of Protective Factors of Bone Mineral Density in a New Orleans Sarcoidosis Population
  • Abstract Number: 1396
    Assessment of Pulmonary Function in Rheumatoid Arthritis Patients Attending Rheumatology Clinics in Nairobi,Kenya
  • Abstract Number: 2096
    Assessment of RA Heterogeneity in Two Independent Cohorts of Patients
  • Abstract Number: 2592
    Assessment of Spondyloarthritis International Society Endorsed Recommendations for Early Referral of Patients Suspected for Axial Spondyloarthritis
  • Abstract Number: 2490
    Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFs and Correlated with Clinical Outcomes As Measured By DAS28(ESR)
  • Abstract Number: 1273
    Assessment of the Effect of Rituximab in the Treatment of Interstitial Lung Disease  associated with the Antisynthetase Syndrome
  • Abstract Number: 2064
    Assessment of the Spanish Version of the American College Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia
  • Abstract Number: 2272
    Assessment of Transition Readiness in Adolescents and Young Adults with Rheumatic and Other Chronic Health Conditions
  • Abstract Number: 2964
    Association Analysis of Apolipoprotein B and Very Low-Density Lipoprotein with Hyperuricemia and Gout
  • Abstract Number: 211
    Association Between Baseline External Knee Adduction and Flexion Moments during Gait and Medial Tibiofemoral Cartilage Thickness Loss over Two Years in Persons with Knee Osteoarthritis (OA)
  • Abstract Number: 1275
    Association Between Cardiometabolic Disorders and Hand Osteoarthritis Severity: A Cross-Sectional and Longitudinal Study
  • Abstract Number: 1635
    Association Between Carrying at Least One Apolipoprotein1 Variant Allele and Hypertension in Lupus Patients with Normal Renal Function
  • Abstract Number: 1438
    Association Between Chronic Inflammatory Conditions and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 2117
    Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
  • Abstract Number: 789
    Association Between Histological Features and Clinical Features of Patients with Biopsy Positive Giant Cell Arteritis
  • Abstract Number: 225
    Association Between Lean Mass and Hip Bone Mineral Density
  • Abstract Number: 806
    Association of a Single Nucleotide Polymorphism (SNP) in IL-12B Region with Clinical Features and Peripheral T Cell Profiles of Patients with Takayasu Arteritis
  • Abstract Number: 2735
    Association of a-Kinase Anchoring Protein-79 (AKAP79) to PKC Mediates Inhibition of IL2 Transcription and Erk Activation in T Cells
  • Abstract Number: 2684
    Association of Adam33 Polymorphisms with Systemic Lupus Erythematosus
  • Abstract Number: 401
    Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
  • Abstract Number: 413
    Association of Antinuclear Antibodies with Lung Disease, Malignancy and Joint Replacement in Rheumatoid Arthritis
  • Abstract Number: 2085
    Association of Circulating Mirnas with Spinal Involvement in Patients with Axial Spondyloarthritis
  • Abstract Number: 864
    Association of Coronary Artery Calcification with Brown and White Pericardial Adipose Tissue in SLE
  • Abstract Number: 1677
    Association of Gastrointestinal Symptoms with Immunosuppressant Use in the Prospective Registry of Early Systemic Sclerosis Cohort
  • Abstract Number: 1651
    Association of Glomerular Macrophage Phenotypes and Urine Soluble CD163 with Disease Activity in Human Lupus Nephritis
  • Abstract Number: 1175
    Association of Hand MRI Findings with the Level of Plasma Cytokines in Patients with Newly Diagnosed Rheumatoid Arthritis
  • Abstract Number: 1788
    Association of HLA-B*41 with Henoch-Schönlein Purpura in Spanish Individuals Irrespective of the HLA-DRB1 Status
  • Abstract Number: 306
    Association of Kawasaki Disease with Tropospheric Winds in Central Chile: Is Wind-Borne Desert Dust a Risk Factor? 
  • Abstract Number: 66
    Association of Knee Osteoarthritis and Limitations in Physical Function in a Rural Chinese Population: The Wuchuan OA Study
  • Abstract Number: 86
    Association of Leukocyte Immunoglobulin-like Receptor A3 (LILRA3) with Systemic Sclerosis
  • Abstract Number: 1278
    Association of Low Birth Weight and Preterm Birth with the Incidence of Knee and Hip Arthroplasty for Osteoarthritis
  • Abstract Number: 1090
    Association of Objectively Measured Physical Activity and Metabolic Syndrome Among Adults with Osteoarthritis in the United States
  • Abstract Number: 386
    Association of Pharmacogenetic Markers with Treatment Response in Patients with Rheumatoid Arthritis
  • Abstract Number: 612
    Association of Platelet Endothelial Cell Adhesion Molecule-1 and beta1 Integrin Gene Polymorphisms with Uveitis Development in Ankylosing Spondylitis
  • Abstract Number: 1140
    Association of Polymorphisms on OPG, RANK and RANKL with ACPA Presence and Erosions: Results of a Meta-Analysis on 1570 Rheumatoid Arthritis Patients from 3 French Cohorts
  • Abstract Number: 2922
    Association of Single Nucleotide Polymorphisms of PADI4 Gene with Susceptibility to Rheumatoid Arthritis-Related Lung Disease
  • Abstract Number: 2585
    Association of Smoking with Acute Phase Reactants and Molecules Involved in Bone Formation in Patients with Ankylosing Spondylitis
  • Abstract Number: 2962
    Association of the Toll-like Receptor 4 (TLR4) Gene with Gout
  • Abstract Number: 2088
    Association of TNFAIP3 Gene Polymorphisms with the Risk for RA and Prediction of  Therapy Outcome of TNFα-Blocker Treatment
  • Abstract Number: 87
    Association of TRIM21 (RO52) Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population
  • Abstract Number: 1336
    Associations of Physical and Mental Factors with Outcome Expectations for Exercise in a Clinical Trial
  • Abstract Number: 2456
    Associations of Toll-like Receptor (TLR)-4 Single Nucleotide Polymorphisms and Rheumatoid Arthritis Disease Progression
  • Abstract Number: 1440
    Asymptomatic Carotid Plaques in RA Patients Are Associated with Increased HDL Function
  • Abstract Number: 829
    Asymptomatic Deposit of Monosodium Urate Crystals Associates to a More Severe Coronary Calcification in Hyperuricemic Patients with Acute Coronary Syndrome
  • Abstract Number: 126
    Asymptomatic Versus Symptomatic Ankle Joints in Rheumatoid Arthritis: A High Resolution B-Mode and Power Doppler Ultrasound Study
  • Abstract Number: 2762
    Atrophy of Hippocampal Region in Chronic Progressive Neuro-Behçet’s Disease
  • Abstract Number: 2427
    Attainment of Low Disease Activity Is Predictive of Maintenance of Disease Control upon Adalimumab Discontinuation for Two Years Following Combination Therapy in Japanese Patients with Early Rheumatoid Arthritis
  • Abstract Number: 2935
    Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis
  • Abstract Number: 1732
    Attenuation of Sclerodermatous Graft Versus Host Disease (sclGVHD) in IL4RA Receptor-Deficient Mice
  • Abstract Number: 2662
    Attribution Protocol and Clinical Significance of Neuropsychiatric Manifestations in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1626
    Autoantibodies Against High Mobility Group Box 1 (HMGB1) in Patients with SLE
  • Abstract Number: 2782
    Autoantibodies from Single Circulating Plasmablasts React with Citrullinated Antigens and Porphyromonas Gingivalis in Rheumatoid Arthritis
  • Abstract Number: 320
    Autoantibodies in Juvenile Systemic Sclerosis
  • Abstract Number: 2541
    Autoantibodies in Pediatric Sjogren’s Patients
  • Abstract Number: 2985
    Autoantibodies to 14-3-3η Are Novel Biomarkers Associated with Inflammation and  Radiographic Progression in Ankylosing Spondylitis
  • Abstract Number: 3004
    Autoantibody-Mediated Raynaud’s Phenomenon: Animal Model and Human Disease
  • Abstract Number: 703
    Autoimmune Hepatitis in Systemic Lupus Erythematosus
  • Abstract Number: 2252
    Autoimmune Thyroid Disease Is Associated with a Higher Frequency of Spinal Degenerative Disc Disease
  • Abstract Number: 1530
    Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis
  • Abstract Number: 149
    Automated Digital Analysis of Major Salivary Gland Ultrasound Images
  • Abstract Number: 2147
    Automatically Extracted Quantitative Biomarkers for Assessing Connective Tissue Disease Using Nailfold Capillaroscopy
  • Abstract Number: 1008
    Autophagy Activation Protects from Mitochondrial Dysfunction in Human Chondrocytes  
  • Abstract Number: 611
    Autophagy and Unfolded Protein Response: A Fine Balance That Can Influence the Pathogenesis of Ankylosing Spondylitis and Inflammatory Bowel Disease
  • Abstract Number: 2690
    Autoregulatory Function of IL-10 Producing Pre-Naïve B Cells Is Defective in Systemic Lupus Erythematosus
  • Abstract Number: 1796
    Autotaxin Is Highly Expressed in Systemic Sclerosis (SSc) Skin, Mediates Dermal Fibrosis Via IL-6, and Is a Target for SSc Therapy
Jump to:  View All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences